The Impact of the COVID Pandemic on Adrenal Surgery at an Academic Endocrine Surgery Unit

Abstract

COVID-19 has severely affected the delivery of surgical care worldwide. The aim of the present study was to evaluate its impact on adrenal surgery at our academic endocrine center. All primary adrenal surgeries performed at the University Hospital of Cologne, Germany between 01.01.2019 and 31.07.2022 were included. This time frame was divided into pre-Covid (before 02/20), acute Covid (until 05/21), and post acute period (after 05/2021). Demographics, clinic-pathologic characteristics and treatment of these patients were analyzed. One hundred adrenalectomies were included: 22 before, 30 during, and 48 after the acute phase. The percentage of Conn adenomas and pheochromocytomas decreased during the acute phase (from 45.4 to 26.6% and from 18 to 10%, respectively) in favor of Cushing adenomas and suspicious tumors (from 4.5 to 20% and from 31.8 to 36.6%). About 90.9% of tumors resected for suspicion of malignancy were confirmed malignant by final histopathology, as opposed to 71.4% and 52.6% before and after the acute phase. The operative technique was similar during the three phases (63% retroperitoneoscopic, 34% laparoscopic and 2% open resections), with a significantly shorter operative time for retroperitoneoscopy (p=0.04). ICU monitoring demand increased during the acute phase (from 13.6% to 43.3%), according to the increase in Cushing adenomas and malignant tumors. During the acute phase of COVID-19 pandemic adrenal surgery for Cushing and malignant tumors increased, while a delay in pheochromocytoma surgery to the post acute phase was observed. The suspicion of malignancy formulated by the endocrine tumor board was accurate in 90.9% of cases.

Key words

adrenal surgery - COVID-19 - pandemic - endocrine tumor board

Publication History

Received: 30 August 2022

Accepted after revision: 23 August 2023

Article published online:
30 October 2023

• References

• 1 Baud G, Brunaud L, Lifante JC. et al. Chirurgie endocrinienne au cours et au décours de l’épidémie de COVID-19: recommandations de l’AFCE [Endocrine surgery during and after the COVID-19 epidemic: Guidelines from AFCE]. J Chir Visc 2020; 157: S44-S51
• 2 Lombardi CP, Gordini L, D’Amore A. et al. COVID-19 pandemic: new rules of engagement in endocrine surgery. Br J Surg 2020; 107: e322
• 3 Lombardi CP, D’Amore A, Grani G. et al. Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?. Endocrine 2020; 68: 485-488
• 4 Chen AY, Shindo M. Ethical framework for head and neck endocrine surgery in the COVID-19 pandemic. Head Neck 2020; 42: 1418-1419
• 5 Raghavan D, Tan AR, Story ES. et al. Management changes for patients with endocrine-related cancers in the COVID-19 pandemic. Endocr Relat Cancer 2020; 27: R357-R374
• 6 Schiavone D, Torresan F, Rossi GP. et al. Reduced adrenal surgery in COVID-19 pandemic: a possible ticking time bomb. Br J Surg 2021; 108: e239-e240
• 7 Groeben H, Nottebaum BJ, Alesina PF. et al. Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth 2017; 118: 182-189
• 8 Chiapponi C, Santos DPD, Hartmann MJM. et al. Adrenal surgery in the era of multidisciplinary endocrine tumor boards. Horm Metab Res 2022; 54: 294-299
• 9 Fassnacht M, Arlt W, Bancos I. et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 2016; 175: G1-G34
• 10 Alesina PF. Retroperitoneal adrenalectomy-learning curve, practical tips and tricks, what limits its wider uptake. Gland Surg 2019; 8: S36-S40
• 11 Schimmack S, Kaiser J, Probst P. et al. Meta-analysis of α-blockade versus no blockade before adrenalectomy for phaeochromocytoma. Br J Surg 2020; 107: e102-e108
• 12 Gambardella C, Pagliuca R, Pomilla G. et al. COVID-19 risk contagion: Organization and procedures in a South Italy geriatric oncology ward. J Geriatr Oncol 2020; 11: 1187-1188
• 13 Tolone S, Gambardella C, Brusciano L. et al. Telephonic triage before surgical ward admission and telemedicine during COVID-19 outbreak in Italy. Effective and easy procedures to reduce in-hospital positivity. Int J Surg 2020; 78: 123-125
• 14 Japp EA, Leiter A, Tsomos EA. et al. Management of 3 cases of pheochromocytoma during the COVID-19 pandemic in New York city: lessons learned. J Endocr Soc 2020; 5: bvaa198
• 15 Pivonello R, Ferrigno R, Isidori AM. et al. COVID-19 and Cushing’s syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol 2020; 8: 654-656